KQED's Forum ‘Drug Story’ Explores the Disease Business one Med at A Time
Jan 6, 2026
Thomas Goetz, journalist and entrepreneur behind the podcast Drug Story, dives deep into the complexities of modern medicine. He discusses how commonly prescribed drugs often represent trial-and-error solutions rather than guaranteed fixes. The conversation highlights the profit motives behind drug pricing, the rise of childhood food allergies, and the over-prescription of medications like statins. Goetz also explores the balance between lifestyle changes and pharmaceutical dependence, challenging listeners to rethink the narrative around health and medicine.
AI Snips
Chapters
Transcript
Episode notes
Patents Incentivize But Can Be Exploited
- Patents are meant to incentivize drug development but can be extended by tweaks to delay generics.
- Goetz warns companies sometimes exploit goodwill and regulatory loopholes.
Risk Targets Drive Mass Preventive Use
- Cholesterol risk became a target after Framingham identified associations like high LDL.
- Lowering treatment cutoffs expanded statin use but swept many unlikely-to-benefit people into treatment.
Individualize Cholesterol Decisions
- Individualize decisions about statins based on family history and diverse risk profiles.
- Primary care must weigh holistic context beyond a single LDL number.